Literature DB >> 25524751

The prescription of addiction medications after implementation of chronic care management for substance dependence in primary care.

Tae Woo Park1, Jeffrey H Samet2, Debbie M Cheng3, Michael R Winter4, Theresa W Kim5, Anna Fitzgerald6, Richard Saitz2.   

Abstract

People with addictive disorders commonly do not receive efficacious medications. Chronic care management (CCM) is designed to facilitate delivery of effective therapies. Using data from the CCM group in a trial testing its effectiveness for addiction (N=282), we examined factors associated with the prescription of addiction medications. Among participants with alcohol dependence, 17% (95% CI 12.0-22.1%) were prescribed alcohol dependence medications. Among those with drug dependence, 9% (95% CI 5.5-12.6%) were prescribed drug dependence medications. Among those with opioids as a substance of choice, 15% (95% CI 9.3-20.9%) were prescribed opioid agonist therapy. In contrast, psychiatric medications were prescribed to 64% (95% CI 58.2-69.4%). Absence of co-morbid drug dependence was associated with prescription of alcohol dependence medications. Lower alcohol addiction severity and recent opioid use were associated with prescription of drug dependence medications. Better understanding of infrequent prescription of addiction medications, despite a supportive clinical setting, might inform optimal approaches to delivering addiction medications.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Acamprosate; Buprenorphine; Chronic care management; Medications; Naltrexone; Substance abuse treatment

Mesh:

Substances:

Year:  2014        PMID: 25524751      PMCID: PMC4382414          DOI: 10.1016/j.jsat.2014.11.008

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  34 in total

1.  Beliefs about evidence-based practices in addiction treatment: a survey of Veterans Administration program leaders.

Authors:  Mark L Willenbring; Daniel Kivlahan; Marie Kenny; Michael Grillo; Hildi Hagedorn; Andrea Postier
Journal:  J Subst Abuse Treat       Date:  2004-03

2.  A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity.

Authors:  J Ware; M Kosinski; S D Keller
Journal:  Med Care       Date:  1996-03       Impact factor: 2.983

3.  Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties.

Authors:  H A Pincus; T L Tanielian; S C Marcus; M Olfson; D A Zarin; J Thompson; J Magno Zito
Journal:  JAMA       Date:  1998-02-18       Impact factor: 56.272

4.  Benefits of linking primary medical care and substance abuse services: patient, provider, and societal perspectives.

Authors:  J H Samet; P Friedmann; R Saitz
Journal:  Arch Intern Med       Date:  2001-01-08

Review 5.  Organizing care for patients with chronic illness.

Authors:  E H Wagner; B T Austin; M Von Korff
Journal:  Milbank Q       Date:  1996       Impact factor: 4.911

6.  The Fifth Edition of the Addiction Severity Index.

Authors:  A T McLellan; H Kushner; D Metzger; R Peters; I Smith; G Grissom; H Pettinati; M Argeriou
Journal:  J Subst Abuse Treat       Date:  1992

Review 7.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10.

Authors:  D V Sheehan; Y Lecrubier; K H Sheehan; P Amorim; J Janavs; E Weiller; T Hergueta; R Baker; G C Dunbar
Journal:  J Clin Psychiatry       Date:  1998       Impact factor: 4.384

8.  A new measure of substance abuse treatment. Initial studies of the treatment services review.

Authors:  A T McLellan; A I Alterman; J Cacciola; D Metzger; C P O'Brien
Journal:  J Nerv Ment Dis       Date:  1992-02       Impact factor: 2.254

Review 9.  Pharmacotherapy for adults with alcohol use disorders in outpatient settings: a systematic review and meta-analysis.

Authors:  Daniel E Jonas; Halle R Amick; Cynthia Feltner; Georgiy Bobashev; Kathleen Thomas; Roberta Wines; Mimi M Kim; Ellen Shanahan; C Elizabeth Gass; Cassandra J Rowe; James C Garbutt
Journal:  JAMA       Date:  2014-05-14       Impact factor: 56.272

10.  A screening trial of amantadine as a medication for cocaine dependence.

Authors:  Steve Shoptaw; P C Kintaudi; Charles Charuvastra; Walter Ling
Journal:  Drug Alcohol Depend       Date:  2002-05-01       Impact factor: 4.492

View more
  4 in total

1.  The Role of Health Plans in Supporting Behavioral Health Integration.

Authors:  Maureen T Stewart; Constance M Horgan; Amity E Quinn; Deborah W Garnick; Sharon Reif; Timothy B Creedon; Elizabeth L Merrick
Journal:  Adm Policy Ment Health       Date:  2017-11

2.  The impact of addiction medications on treatment outcomes for persons with co-occurring PTSD and opioid use disorders.

Authors:  Elizabeth C Saunders; Mark P McGovern; Chantal Lambert-Harris; Andrea Meier; Bethany McLeman; Haiyi Xie
Journal:  Am J Addict       Date:  2015-09-21

Review 3.  Implementing Effective Substance Abuse Treatments in General Medical Settings: Mapping the Research Terrain.

Authors:  Lori J Ducharme; Redonna K Chandler; Alex H S Harris
Journal:  J Subst Abuse Treat       Date:  2015-07-08

4.  Adaptations to Opioid Use Disorder Care During the COVID-19 Pandemic: A National Survey of Prescribers.

Authors:  Minhee L Sung; Anne C Black; Derek Blevins; Brandy F Henry; Kathryn Cates-Wessel; Michael A Dawes; Karen Drexler; Holly Hagle; Todd Molfenter; Frances R Levin; William C Becker; E Jennifer Edelman
Journal:  J Addict Med       Date:  2022-01-11       Impact factor: 4.647

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.